On 2026-10-06, a clinical trial record involving teriparatide was updated on ClinicalTrials.gov. The trial, titled "PROactive HEALing in High-Risk Pelvic and Non-hip Lower Extremity Fragility Fractures (PRO HEAL Pilot)," is registered as NCT06303284. It is listed as a Phase 1/Phase 2 study. According to the current record, the trial status is not yet recruiting. No participant results, efficacy data, or safety findings have been posted for this trial as of this update. Teriparatide is an approved compound, and this listing reflects a study examining its use in a specific fracture population. The trial registry entry provides the title, phase, and status as the available facts at this time. Interested readers can review the official listing for further details on eligibility, design, and future recruitment timelines as the study progresses. This brief reflects only the information contained in the trial record as of the stated date and does not include any outcome or interim data. For more background on teriparatide, see the compound overview linked with this article.
Teriparatide Trial "PRO HEAL Pilot" Listed as Not Yet Recruiting
See the full teriparatide overview
Source: https://clinicaltrials.gov/study/NCT06303284